密螺旋体
抗原
生物
免疫学
T细胞
病毒学
表位
T淋巴细胞
埃利斯波特
免疫系统
梅毒
CD8型
人类免疫缺陷病毒(HIV)
作者
Tara B. Reid,Charmie Godornes,Victoria Campbell,Kerry J. Laing,Lauren C. Tantalo,Alloysius Gomez,Thepthara Pholsena,Nicole A. P. Lieberman,Taylor Krause,Victoria Cegielski,Lauren A. Culver,Nhi Nguyen,Denise Q. Tong,Kelly L. Hawley,Alexander L. Greninger,Lorenzo Giacani,Caroline E. Cameron,Julia C. Dombrowski,Anna Wald,David M. Koelle
标识
DOI:10.1093/infdis/jiae245
摘要
Abstract Background Histologic and serologic studies suggest the induction of local and systemic Treponema pallidum-specific CD4+ T-cell responses to T. pallidum infection. We hypothesized that T. pallidum-specific CD4+ T cells are detectable in blood and in the skin rash of secondary syphilis and persist in both compartments after treatment. Methods Peripheral blood mononuclear cells collected from 67 participants were screened by interferon-γ (IFN-γ) ELISPOT response to T. pallidum sonicate. T. pallidum-reactive T-cell lines from blood and skin were probed for responses to 89 recombinant T. pallidum antigens. Peptide epitopes and HLA class II restriction were defined for selected antigens. Results We detected CD4+ T-cell responses to T. pallidum sonicate ex vivo. Using T. pallidum-reactive T-cell lines we observed recognition of 14 discrete proteins, 13 of which localize to bacterial membranes or the periplasmic space. After therapy, T. pallidum-specific T cells persisted for at least 6 months in skin and 10 years in blood. Conclusions T. pallidum infection elicits an antigen-specific CD4+ T-cell response in blood and skin. T. pallidum-specific CD4+ T cells persist as memory in both compartments long after curative therapy. The T. pallidum antigenic targets we identified may be high-priority vaccine candidates.
科研通智能强力驱动
Strongly Powered by AbleSci AI